Table 3.
Study | Pop-Eleche et al | Mbuagbaw et al* | Lester et al | Da Costa et al* |
---|---|---|---|---|
Location | Kenya | Cameroon | Kenya | India |
Timing | Weekly/Daily | Weekly | Weekly | Weekly |
Length | Long/Short | Long | Short | NA |
Feedback | No | Yes | Yes | No |
Content | Motivational | Motivational | Support/Access | Picture |
Sending | Automated | Manual | Manual | Automated |
Measurement | MEMS | VAS/SR/PRD | SR/VL | VL (TTE)/SR |
Variety | No | Yes | No | No |
Duration | 12 months | 6 months | 12 months | 24 months |
Phone provided | Yes | No | No | Yes |
Sample size | 431 | 198 | 538 | 600 |
*Based on protocol; SR: Self Report; VL: Viral Load; PRD: Pharmacy Refill Data; TTE: Time-to-event; MEMS: Medication Event Monitoring System